Private Advisor Group LLC acquired a new stake in shares of Certara, Inc. (NASDAQ:CERT - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 23,568 shares of the company's stock, valued at approximately $251,000.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Venturi Wealth Management LLC boosted its stake in Certara by 839.1% in the 4th quarter. Venturi Wealth Management LLC now owns 2,808 shares of the company's stock worth $30,000 after purchasing an additional 2,509 shares during the period. Blue Trust Inc. boosted its position in shares of Certara by 20.9% during the fourth quarter. Blue Trust Inc. now owns 4,747 shares of the company's stock worth $56,000 after acquiring an additional 822 shares during the last quarter. KBC Group NV boosted its position in shares of Certara by 48.2% during the third quarter. KBC Group NV now owns 4,873 shares of the company's stock worth $57,000 after acquiring an additional 1,584 shares during the last quarter. GAMMA Investing LLC grew its stake in Certara by 442.2% during the fourth quarter. GAMMA Investing LLC now owns 8,421 shares of the company's stock valued at $90,000 after acquiring an additional 6,868 shares in the last quarter. Finally, Moloney Securities Asset Management LLC bought a new stake in Certara in the 4th quarter valued at $128,000. 73.96% of the stock is currently owned by institutional investors.
Certara Trading Down 3.9 %
Shares of NASDAQ:CERT traded down $0.46 during trading on Monday, hitting $11.27. The company had a trading volume of 1,888,940 shares, compared to its average volume of 1,347,708. The stock has a market cap of $1.81 billion, a price-to-earnings ratio of -56.35, a price-to-earnings-growth ratio of 9.29 and a beta of 1.60. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.86 and a quick ratio of 2.86. The company has a fifty day simple moving average of $12.56 and a two-hundred day simple moving average of $11.61. Certara, Inc. has a one year low of $9.41 and a one year high of $19.39.
Wall Street Analysts Forecast Growth
CERT has been the subject of a number of research analyst reports. Barclays raised their price objective on Certara from $12.00 to $13.00 and gave the company an "equal weight" rating in a research report on Friday, February 28th. Stephens reissued an "overweight" rating and set a $17.00 price target on shares of Certara in a research note on Thursday, February 27th. TD Cowen began coverage on Certara in a research note on Thursday, February 27th. They issued a "buy" rating and a $16.00 price objective on the stock. Finally, William Blair reiterated a "market perform" rating on shares of Certara in a research report on Thursday, February 27th. Four analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $15.83.
View Our Latest Research Report on Certara
Certara Profile
(
Free Report)
Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.
Further Reading
Before you consider Certara, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Certara wasn't on the list.
While Certara currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
